Close

Leerink Partners Upgrades AstraZeneca (AZN) to Outperform

December 9, 2016 7:40 AM EST
Get Alerts AZN Hot Sheet
Price: $67.75 -0.75%

Rating Summary:
    17 Buy, 8 Hold, 3 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE

Leerink Partners upgraded AstraZeneca (NYSE: AZN) from Market Perform to Outperform with a price target of $34.

For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.

Shares of AstraZeneca closed at $26.27 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades